Life Science Partnering
This group will provide life science partnering news and information on events, sectors and topics of interest here on partnering360. Look for upcoming features and discussions intended to maximize your partnering experience.
BioMedTracker's drug development Outlook Report for 3Q 2015 has just been released with their list of large-impact catalysts. This quarter’s list includes over 20 highlights plus a few medtech entries and a catalyst calendar. How do reports like this change your drug development partnering strategy at partnering events such as BioPharm America? Read the post on partnering360® Blog> http://bit.ly/1D8JOmK
Johnson &Johnson Innovation is a trend setter because of their biotech investment model and approach as a community-based hub focused on discovery, community and knowing where innovation happens. Why do you think it works and how can we make it better?
Read more on #p360Blog> http://bit.ly/1LyzRlr
According to The Life Sciences Report Small-Cap Biotech Watchlist, catalysts move stock prices and some catalysts move stocks more than others.
Read today's guest post by Jim Patrick, publisher, The Life Sciences Report called "What to Look for in Companies Navigating Drug Approval Processes on Both Sides of the Pond" at http://bit.ly/1Egu4gT. And share your opinion here.
We are proud to announce that CELONIC in 2014, showed top performance amongst CMO's for biologics worldwide by achieving productivity levels of more than 7 g/L for a biosimilar monoclonal antibody!
We look forward to another exciting year with you in 2015.
Stay tuned with us!
email at: firstname.lastname@example.org
Stavros Theocharidis – Biologist, MSc
Eulerstrasse 55, 4051 Basel, Switzerland
Today, we profile Recursion Pharmaceuticals and their unique innovative method to finding drugs that can treat rare diseases. http://www.partnering360.com/blog/2015/01/23/recursion-pharmaceuticals-innovative-alternative-to-drug-discovery/